CONTACT INFORMATION
Specialties
Breast Cancer, Lung Cancer, Cancer Survivorship, Cancer in Seniors, Chemoprevention of Breast Cancer, Chemoprevention of Lung Cancer, Mesothelioma
Locations
Board Certifications
Internal Medicine - General Cert: AM Board of Internal Medicine
Medical Oncology - Subspecialty Cert: AM Board of Internal Medicine
Publications
Developing Safety Criteria for Introducing New Agents into Neoadjuvant Trials Demichele,A.; Berry,D. A.; Zujewski,J.; Hunsberger,S.; Rubinstein,L.; Tomaszewski,J. E.; Kelloff,G.; Perlmutter,J.; Buxton,M.; Lyandres,J.; Albain,K. S.; Benz,C.; Chien,A. J.; Haluska,P.; Leyland-Jones,B.; Liu,M. C.; Munster,P.; Olopade,O.; Park,J. W.; Parker,B. A.; Pusztai,L.; Tripathy,D.; Rugo,H.; Yee,D.; Esserman,L. Clinical cancer research : an official journal of the American Association for Cancer Research 2013 ; ( ):
Phase II Trial of Simple Oral Therapy with Capecitabine and Cyclophosphamide in Patients with Metastatic Breast Cancer: SWOG S0430 Schott,A. F.; Barlow,W. E.; Albain,K. S.; Chew,H. K.; Wade,J. L.; Lanier,K. S.; Lew,D. L.; Hayes,D. F.; Gralow,J. R.; Livingston,R. B.; Hortobagyi,G. N. Oncologist 2012 ;17(2):179-188
Impact of Multigene Assays in Early Stage Breast Cancer Lo,Shelly, S.; Albain,Kathy, S. Oncologist 2011 ;16(11):1482-1483
Targeting both Notch and ErbB-2 signalling pathways is required for prevention of ErbB-2-positive breast tumour recurrence. Pandya,K.; Meeke,K.; Clementz,A. G.; Rogowski,A.; Roberts,J.; Miele,L.; Albain,K. S.; Osipo,C. British journal of cancer 2011 ;105(6):796-806
Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial. Albain,K. S.; Barlow,W. E.; Shak,S.; Hortobagyi,G. N.; Livingston,R. B.; Yeh,I. T.; Ravdin,P.; Bugarini,R.; Baehner,F. L.; Davidson,N. E.; Sledge,G. W.; Winer,E. P.; Hudis,C.; Ingle,J. N.; Perez,E. A.; Pritchard,K. I.; Shepherd,L.; Gralow,J. R.; Yoshizawa,C.; Allred,D. C.; Osborne,C. K.; Hayes,D. F. Lancet Oncology 2010 ;11(1):55-65
Proceedings of the first global workshop on breast cancer: pathways to the evaluation and clinical development of novel agents for breast cancer Albain,K. S.; Carey,L.; Gradishar,W. J.; Gralow,J. R.; Lipton,A.; Rugo,H.; Tripathy,D.; Peck,S.; Abair,T.; Pegram,M. Clinical Breast Cancer 2010 ;10(6):421-439
Inhibition of Notch signaling reduces the stem-like population of breast cancer cells and prevents mammosphere formation. Grudzien,P.; Lo,S.; Albain,K. S.; Robinson,P.; Rajan,P.; Strack,P. R.; Golde,T. E.; Miele,L.; Foreman,K. E. Anticancer Research 2010 ;30(10):3853-3867
Prospective multicenter study of the impact of the 21-gene recurrence score assay on medical oncologist and patient adjuvant breast cancer treatment selection. Lo,S. S.; Mumby,P. B.; Norton,J.; Rychlik,K.; Smerage,J.; Kash,J.; Chew,H. K.; Gaynor,E. R.; Hayes,D. F.; Epstein,A.; Albain,K. S. Journal of Clinical Oncology 2010 ;28(10):1671-1676
Lung cancer outcomes in women. Shafer,D.; Albain,K. Seminars in oncology 2009 ;36(6):532-541
Prediction of adjuvant chemotherapy benefit in endocrine responsive, early breast cancer using multigene assays Albain,K. S.; Paik,S.; van't Veer,L. Breast 2009 ;18(Suppl 3):S141-5
Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial Albain,K. S.; Swann,R. S.; Rusch,V. W.; Turrisi,A. T.,3rd; Shepherd,F. A.; Smith,C.; Chen,Y.; Livingston,R. B.; Feins,R. H.; Gandara,D. R.; Fry,W. A.; Darling,G.; Johnson,D. H.; Green,M. R.; Miller,R. C.; Ley,J.; Sause,W. T.; Cox,J. D. Lancet 2009 ;374(9687):379-386
Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group Albain,K. S.; Unger,J. M.; Crowley,J. J.; Coltman,C. A.,Jr; Hershman,D. L. Journal of the National Cancer Institute 2009 ;101(14):984-992
Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive, node-positive breast cancer: a phase 3, open-label, randomised controlled trial Albain,K. S.; Barlow,W. E.; Ravdin,P. M.; Farrar,W. B.; Burton,G. V.; Ketchel,S. J.; Cobau,C. D.; Levine,E. G.; Ingle,J. N.; Pritchard,K. I.; Lichter,A. S.; Schneider,D. J.; Abeloff,M. D.; Henderson,I. C.; Muss,H. B.; Green,S. J.; Lew,D.; Livingston,R. B.; Martino,S.; Osborne,C. K. Lancet 2009 ;374(9707):2055-2063
Prevalence of secondary causes of bone loss among breast cancer patients with osteopenia and osteoporosis. Camacho,P. M.; Dayal,A. S.; Diaz,J. L.; Nabhan,F. A.; Agarwal,M.; Norton,J. G.; Robinson,P. A.; Albain,K. S. Journal of Clinical Oncology 2008 ;26(33):5380-5385
Phase III randomized placebo-controlled trial of two doses of megestrol acetate as treatment for menopausal symptoms in women with breast cancer: Southwest Oncology Group Study 9626. Goodwin,J. W.; Green,S. J.; Moinpour,C. M.; Bearden,J. D.,3rd; Giguere,J. K.; Jiang,C. S.; Lippman,S. M.; Martino,S.; Albain,K. S. Journal of Clinical Oncology 2008 ;26(10):1650-1656
Late cardiac effects of adjuvant chemotherapy in breast cancer survivors treated on Southwest Oncology Group protocol s8897 Ganz,P. A.; Hussey,M. A.; Moinpour,C. M.; Unger,J. M.; Hutchins,L. F.; Dakhil,S. R.; Giguere,J. K.; Goodwin,J. W.; Martino,S.; Albain,K. S. Journal of Clinical Oncology 2008 ;26(8):1223-1230
Gemcitabine plus Paclitaxel versus Paclitaxel monotherapy in patients with metastatic breast cancer and prior anthracycline treatment. Albain,K. S.; Nag,S. M.; Calderillo-Ruiz,G.; Jordaan,J. P.; Llombart,A. C.; Pluzanska,A.; Rolski,J.; Melemed,A. S.; Reyes-Vidal,J. M.; Sekhon,J. S.; Simms,L.; O'Shaughnessy,J. Journal of Clinical Oncology 2008 ;26(24):3950-3957
Phase III trial of maintenance gefitinib or placebo after concurrent chemoradiotherapy and docetaxel consolidation in inoperable stage III non-small-cell lung cancer: SWOG S0023 Kelly,K.; Chansky,K.; Gaspar,L. E.; Albain,K. S.; Jett,J.; Ung,Y. C.; Lau,D. H.; Crowley,J. J.; Gandara,D. R. Journal of Clinical Oncology 2008 ;26(15):2450-2456
Cross-talk between notch and the estrogen receptor in breast cancer suggests novel therapeutic approaches Rizzo,P.; Miao,H.; D'Souza,G.; Osipo,C.; Song,L. L.; Yun,J.; Zhao,H.; Mascarenhas,J.; Wyatt,D.; Antico,G.; Hao,L.; Yao,K.; Rajan,P.; Hicks,C.; Siziopikou,K.; Selvaggi,S.; Bashir,A.; Bhandari,D.; Marchese,A.; Lendahl,U.; Qin,J. Z.; Tonetti,D. A.; Albain,K.; Nickoloff,B. J.; Miele,L. Cancer research 2008 ;68(13):5226-5235
A phase II study of cisplatin preceded by a 12-h continuous infusion of concurrent hydroxyurea and cytosine arabinoside (Ara-C) for adult patients with malignant gliomas (Southwest Oncology Group S9149). Swinnen,L. J.; Rankin,C.; Carraway,H.; Albain,K. S.; Townsend,J. J.; Budd,G. T.; Kish,J. A.; Rivkin,S. E.; Blumenthal,D. T. Journal of neuro-oncology 2008 ;86(3):353-358
Impact of a peer-delivered telephone intervention for women experiencing a breast cancer recurrence. Gotay,C. C.; Moinpour,C. M.; Unger,J. M.; Jiang,C. S.; Coleman,D.; Martino,S.; Parker,B. J.; Bearden,J. D.; Dakhil,S.; Gross,H. M.; Lippman,S.; Albain,K. S. Journal of Clinical Oncology 2007 ;25(15):2093-2099
p27(Kip1) and cyclin E expression and breast cancer survival after treatment with adjuvant chemotherapy Porter,P. L.; Barlow,W. E.; Yeh,I. T.; Lin,M. G.; Yuan,X. P.; Donato,E.; Sledge,G. W.; Shapiro,C. L.; Ingle,J. N.; Haskell,C. M.; Albain,K. S.; Roberts,J. M.; Livingston,R. B.; Hayes,D. F. Journal of the National Cancer Institute 2006 ;98(23):1723-1731
New developments in the epidemiology of cancer prognosis: traditional and molecular predictors of treatment response and survival Ambrosone,C. B.; Rebbeck,T. R.; Morgan,G. J.; Albain,K. S.; Calle,E. E.; Evans,W. E.; Hayes,D. F.; Kushi,L. H.; McLeod,H. L.; Rowland,J. H.; Ulrich,C. M. Cancer Epidemiology, Biomarkers & Prevention 2006 ;15(11):2042-2046
Long-term survival with concurrent chemoradiation therapy followed by consolidation docetaxel in stage IIIB non-small-cell lung cancer: a phase II Southwest Oncology Group Study (S9504). Gandara,D. R.; Chansky,K.; Albain,K. S.; Gaspar,L. E.; Lara,P. N.,Jr; Kelly,K.; Crowley,J.; Livingston,R. Clinical Lung Cancer 2006 ;8(2):116-121
Impact of the year 2000 Medicare policy change on older patient enrollment to cancer clinical trials. Unger,J. M.; Coltman,C. A.,Jr; Crowley,J. J.; Hutchins,L. F.; Martino,S.; Livingston,R. B.; Macdonald,J. S.; Blanke,C. D.; Gandara,D. R.; Crawford,E. D.; Albain,K. S. Journal of Clinical Oncology 2006 ;24(1):141-144
Randomized phase III study of trastuzumab, paclitaxel, and carboplatin compared with trastuzumab and paclitaxel in women with HER-2-overexpressing metastatic breast cancer. Robert,N.; Leyland-Jones,B.; Asmar,L.; Belt,R.; Ilegbodu,D.; Loesch,D.; Raju,R.; Valentine,E.; Sayre,R.; Cobleigh,M.; Albain,K.; McCullough,C.; Fuchs,L.; Slamon,D. Journal of Clinical Oncology 2006 ;24(18):2786-2792
Clinical factors used to support prophylactic mastectomy for a male BRCA2 mutation carrier. Guiahi,M.; Gabram,S. G.; Albain,K. S.; Camacho,P. M.; Krishnamachari,B.; Rajan,P. Surgery 2006 ;139(5):704-706
Acute lung injury associated with vinorelbine. Tanvetyanon,T.; Garrity,E. R.; Albain,K. S. Journal of Clinical Oncology 2006 ;24(12):1952-1953
PIONEER: a phase III randomized trial of paclitaxel poliglumex versus paclitaxel in chemotherapy-naive women with advanced-stage non-small-cell lung cancer and performance status of 2. Albain,K. S.; Belani,C. P.; Bonomi,P.; O'Byrne,K. J.; Schiller,J. H.; Socinski,M. Clinical Lung Cancer 2006 ;7(6):417-419
Correlation of nipple aspiration and ductal lavage cytology with histopathologic findings for patients before scheduled breast biopsy examination. West,K. E.; Wojcik,E. M.; Dougherty,T. A.; Siziopikou,K. P.; Albain,K. S.; Gabram,S. G. American Journal of Surgery 2006 ;191(1):57-60
Reducing the global breast cancer burden: the importance of patterns of care research Albain,K. S.; de la Garza Salazar,J.; Pienkowski,T.; Aapro,M.; Bergh,J.; Caleffi,M.; Coleman,R.; Eiermann,W.; Icli,F.; Pegram,M.; Piccart,M.; Snyder,R.; Toi,M.; Hortobagyi,G. N. Clinical Breast Cancer 2005 ;6(5):412-420
Multimodality therapy for stage III non-small-cell lung cancer.[erratum appears in J Clin Oncol. 2005 Oct 20;23(30):7763] Farray,D.; Mirkovic,N.; Albain,K. S. Journal of Clinical Oncology 2005 ;23(14):3257-3269
Positive immunohistochemistry in histologically negative sentinel noeds: affect on adjuvant therapy in early-stage breast cancer. Stradling,B.; Albain,K.; Siziopikou,K.; Wilcoxson,L.; Aranha,G. V.; Shayani,V.; Fisher,S.; Grabram,S. Surgical Rounds 2002 ;25(11):535-542
Education
Medical School
University of Michigan Medical School
Residency
University of Illinois at Chicago Medical Center, Internal Medicine: General
Fellowship
University of Chicago Hospitals and Clinics, Internal Medicine: Hematology & Medical Oncology
Interests & Hobbies
Classical Music
Travel
Family/Friends
Bicycling
Reading
Pipe Organ
Hiking
Singing
Exercise